April 18, 2007

Dr. John Ambroseo, President and CEO, Coherent, Inc., 4-19-07


Download Podcast

Dr. John Ambroseo is the President and Chief Executive Officer of Coherent, Inc. Dr. Ambroseo joined Coherent in August 1988. Since June 2001, he served in the role of Executive Vice President and Chief Operating Officer until becoming President and Chief Executive Officer in October 2002. During his 19-year tenure at Coherent, he held various positions in domestic and international operations, marketing, and sales. He is the past President of LEOMA (Laser Electro-Optics Manufacturers Association) and is a trustee with the Purchase College Foundation. Dr. Ambroseo received his Ph.D. in Chemistry from the University of Pennsylvania and his Bachelor’s degree from the State University of New York College at Purchase.

Founded in 1966, Coherent, Inc. (NASDAQ: COHR) has production and research facilities spanning the world, supplying everything from laser systems and components to laser measurement and control products and precision optics to over 80 countries. Many of its customers are Fortune 500 leading manufacturers and scientific researchers from numerous universities and institutes across the Americas, Europe, and Pacific Rim. With over half a billion in sales in fiscal 2006, the company has attained a scale unrivaled by most of its competitors.

Posted by David Lemberg at 03:48 PM Return to Science and Society Podcasts Main Index

April 05, 2007

Dr. Steven Aldana, Professor of Lifestyle Medicine, Department of Exercise Sciences, Brigham Young University, and Adjunct Faculty, University of Illinois School of Medicine, 4-5-07


Download Podcast

Steven G. Aldana, Ph.D., is a Professor of Lifestyle Medicine in the Department of Exercise Sciences at Brigham Young University in Provo, UT, and an adjunct faculty member at the University of Illinois School of Medicine. One of the nation’s leading health experts, Dr. Aldana is a regular consultant to the National Institutes of Health, the Centers for Disease Control and Prevention, and the National Cancer Institute. He is also the lead scientist on several large lifestyle research trials.

Dr. Aldana is the author of The Culprit and the Cure and a new pocket reference, The Stop & Go Fast Food Nutrition Guide, which offers at-a-glance nutritional information about America's favorite fast foods.

Posted by David Lemberg at 07:40 AM Return to Science and Society Podcasts Main Index

February 14, 2007

Dr. Gabriella Petrick, Assistant Professor of Nutrition and Food Studies, New York University, 2-15-07


Download Podcast

Dr. Gabriella M. Petrick is an Assistant Professor of Nutrition and Food Studies at New York University’s Department of Nutrition, Food Studies, and Public Health where she is working to develop a new program on the food system. She has a background in economics and history and holds degrees from the College of the Holy Cross (A.B.), the Culinary Institute of American (A.O.S.), Cornell University (M.M.H.), and Carnegie Mellon University (M.A.). Her Ph.D. is in U.S. History from the University of Delaware where she was a Hagley Fellow in the History of Technology and Industrialization.

Some of the fellowships Dr. Petrick has held include a National Science Foundation Dissertation Improvement Grant, the Henry Belin Du Pont Dissertation Fellowship, the Deans Fellowship in the History of Home Economics, Cornell University, the Edelstein Studentship, Chemical Heritage Foundation, in addition to being a University Fellow at the University of Delaware. Dr. Petrick’s current research focuses on the scientific and technological development of the food industry and consumer adoption of these new technologies.

Early in her career, Dr. Petrick worked with Gary Danko of Danko’s in San Francisco, Johnathan Waxman of Barbuto in New York, and Madeline Kamman at Beringer Vineyards where she developed an expertise in food and wine pairing. She brought this expertise in the organoleptic evaluation of foods into her historical research by developing the concept of the industrialization of taste in an effort to understand how consumers adopt new food technologies into their diets.

Dr. Petrick has published in the Cornell Quarterly, Agricultural History and has an article forthcoming in the Journal of American History. She is currently working on a book on the industrialization of taste in twentieth-century America.

Posted by David Lemberg at 04:09 PM Return to Science and Society Podcasts Main Index

November 01, 2006

Dr. Colleen Jonsson, Senior Scientist, Emerging Infectious Disease Research Program, Southern Research Institute, 11-3-06


Download Podcast

Dr. Colleen B. Jonsson is a Senior Scientist for the Emerging Infectious Disease Research Program at Southern Research Institute. She has served as a consultant for the Pan American Health Organization in Honduras, Panama and Mexico, in addition to holding several workshops in hantavirus diagnostic methods in Paraguay and Honduras.

Dr. Jonsson has served as a reviewer for NIH and NSF study sections including the NIH Biodefense Vaccine Study Section and BioTerrorism and Emerging Infectious Diseases Study Section, AIDS Structural Biology Panel, NSF Ecology of Infectious Disease Panel and DOD and NSF Graduate Fellowships panel. Dr. Jonsson has served as a reviewer for several journals including American Journal of Tropical Medicine and Hygeine, Antiviral Research, PNAS, Proteins, Virology, Biochemistry, Journal of Infectious Disease, and Nucleic Acids Research.

Dr. Jonsson's research program offers over 15 years of experience in the study of highly pathogenic human viruses at BSL2 and BSL3, and an additional 10 years of experience in bacterial and fungal pathogens of plants at BSL2. Her research program is focused in three areas —

  • The discovery of new therapeutics through the development and assessment of antiviral and vaccine therapeutics and development and characterization of animal models for viruses

  • The ecology of infectious diseases

  • Basic aspects of the virus life cycle such as viral assembly and replication, drug resistance
  • Posted by David Lemberg at 03:07 PM Return to Science and Society Podcasts Main Index

    October 19, 2006

    Dr. Thomas Rowe, Program Leader — Influenza, Drug Development Division — Southern Research Institute, 10-20-06


    Download Podcast

    Thomas Rowe is Program Leader — Influenza, Drug Development Division — at Southern Research Institute, located in Birmingham, AL. Southern Research is a not-for-profit organization that conducts basic and applied research in the areas of preclinical drug discovery and drug development, advanced engineering, environmental and energy production. Southern Research Institute clients include National Institute of Health, the U.S. Departments of Justice, Defense and Energy, Environmental Protection Agency, and NASA.

    Mr. Rowe’s research interests include development of improved vaccines for biological threat agents, development of diagnostic assays for the detection of newly emerging viruses, and cell-mediated immune responses to respiratory viruses. Mr. Rowe has authored or co-authored more than 60 professional articles, abstracts, and presentations. He is a member of American Biological Safety Association, American Society for Microbiology, and American Society for Virology.

    Posted by David Lemberg at 02:22 PM Return to Science and Society Podcasts Main Index

    October 06, 2006

    Dr. Steven Salzberg, Director of the Center for Bioinformatics and Computational Biology, and Horvitz Professor of Computer Science at the University of Maryland, 10-6-06


    Download Podcast

    Dr. Steven Salzberg is the Director of the Center for Bioinformatics and Computational Biology (CBCB) and the Horvitz Professor of Computer Science at the University of Maryland, College Park. For much of the past ten years, Dr. Salzberg has been working on the analysis of genomes in collaboration with colleagues at The Institute for Genomic Research and at other research centers around the world. He was part of the team that published the human genome in 2001, and has participated in the sequencing of genomes from a long list of human pathogens, including the microbes responsible for anthrax, Lyme disease, tuberculosis, and malaria. His group devotes much of its effort to the development of software for genome analysis, and they have been among the leading advocates of open-source software development in the genomics field. In 2004, Dr. Salzberg was one of the founders of the Influenza Genome Sequencing Project, which is now in the process of sequencing thousands of isolates of the influenza virus, in an effort to help design better vaccines and to better understand the nature of influenza pandemics.

    Dr. Salzberg has authored or co-authored two books and over 125 publications in leading scientific journals, and he currently serves on the editorial boards of seven journals. He is a Fellow of the American Association for the Advancement of Science and a member of the Board of Scientific Counsellors of the National Center for Biotechnology Information at NIH.

    The University of Maryland Center for Bioinformatics and Computational Biology (CBCB) is a multidisciplinary center dedicated to research on questions arising from the genome revolution. CBCB brings together scientists and engineers from many fields, including computer science, molecular biology, genomics, mathematics, statistics, physics, and biochemistry, all of whom share a common interest in gaining a better understanding of how life works.

    Posted by David Lemberg at 09:00 AM Return to Science and Society Podcasts Main Index

    September 30, 2006

    Dr. Alan Paau, Assistant Vice Chancellor, Technology Transfer and Intellectual Property Services, and Dr. Arthur B. Ellis, Vice Chancellor for Research, University of California, San Diego, 9/29/06


    Download Podcast

    Prior to joining UC San Diego as Assistant Vice Chancellor, Technology Transfer and Intellectual Property Services, Dr. Alan Paau was Executive Director of the Iowa State University Research Foundation, Inc. and Director of Intellectual Property & Technology Transfer at Iowa State University. Previously, he was Associate Director of the Biotechnology Center at the Ohio State University with responsibilities in research administration, technology management, and industry liaison. Dr. Paau held faculty appointments while at Iowa State University in the departments of Preventive Medicine, Immunology & Microbiology, and Genetics & Zoology, and at the Ohio State University in the departments of Microbiology, and Plant Pathology.

    Dr. Paau is the inventor to eight U.S. patents and has contributed 30 peer-reviewed research articles to scientific journals and six invited reviews/chapters to technical books. As a director of intellectual property and a licensing executive, he supervised the execution of over 800 licenses and option agreements and the formation of over 90 startup companies using university innovations.

    Dr. Arthus Ellis, who joined UC San Diego on September 1, 2006, comes from the National Science Foundation, where he served as the Director for the Division of Chemistry. He is an internationally recognized chemist and widely known for his leadership in advancing the mission of research in the University to create and communicate new knowledge. Dr. Ellis holds Ph.D. and B.S. degrees in chemistry from MIT and Caltech, respectively.

    Dr. Ellis has served as Meloche-Bascom Professor of Chemistry and as the Chair of the Graduate Materials Science Program at the University of Wisconsin at Madison. Among his many awards are Guggenheim and Sloan Fellowships, the National Science Foundation Director’s Meritorious Service Award and the NSF’s Distinguished Teaching Scholar Award. Dr. Ellis and his co-workers have published more than 200 research papers in leading scientific journals and obtained nine patents.

    Posted by David Lemberg at 11:20 AM Return to Science and Society Podcasts Main Index

    September 23, 2006

    Dr. Eric Neumann, Co-Chair, W3C Healthcare and Life Sciences, and Senior Director of Product Strategy, Teranode Corporation, Part One, 9/22/06


    Download Podcast

    Dr. Eric Neumann comes to Teranode Corporation with nearly 20 years of experience in bioinformatics and semantic technologies development. He was previously responsible for negotiating key partnerships with IT vendors and pharmaceutical companies, as well as developing knowledge management and Semantic Web standards for various life sciences initiatives. Prior to joining Teranode, Dr. Neumann held executive positions and developed semantic technologies for Sanofi-Aventis Pharmaceuticals, Beyond Genomics, NetGenics, and Bolt, Beranek, and Newman.

    Dr. Neumann is Co-Chair, W3C Healthcare and Life Sciences.

    Posted by David Lemberg at 10:37 AM Return to Science and Society Podcasts Main Index

    Dr. Eric Neumann, Co-Chair, W3C Healthcare and Life Sciences, and Senior Director of Product Strategy, Teranode Corporation, Part Two, 9/22/06


    Download Podcast

    We continue our conversation with Dr. Eric Neumann, Co-Chair, W3C Healthcare and Life Sciences, and Senior Director of Product Strategy, Teranode Corporation.

    Posted by David Lemberg at 10:31 AM Return to Science and Society Podcasts Main Index

    June 08, 2006

    Dr. Vincent Pieribone, co-author, Aglow in the Dark -- The Revolutionary Science of Biofluorescence, 6/7/06


    Download Podcast

    Dr. Vincent Pieribone is co-author of Aglow in the Dark: he Revolutionary Science of Biofluorescence, recently published by Harvard University Press. Aglow in the Dark conveys the human fascination with bioluminescence, or “living light”, its little-known application in war, forensic science, and molecular biology, and how it led to the discovery of green fluorescent protein. Uses of bioluminescence include studying brain physiology, treatment of disease, and potential applications linking minds and machines.

    Dr. Pieribone is Associate Fellow, The John B. Pierce Laboratory, and Associate Professor, Cellular & Molecular Physiology and Neurobiology, Yale University School of Medicine. He attended New York University College of Arts and Sciences where he received a B.A. in Biology and Chemistry in 1986. He then attended New York University's Graduate School of Arts and Sciences and received his Ph.D. in 1992 in neuroanatomy and neurophysiology. From 1990 to 1992 he was a National Science Foundation and Fogarty International Fellow at the Nobel Institute of Neurophysiology at the Karolinska Institute in Stockholm, Sweden. Dr. Pieribone did postdoctoral work at The Rockefeller University in New York from 1992 to 1995 and became an Assistant Professor there in 1995. He joined the Pierce Laboratory in 1997.

    is co-author of Aglow in the Dark: he Revolutionary Science of Biofluorescence, recently published by Harvard University Press. Aglow in the Dark conveys the human fascination with bioluminescence, or “living light”, its little-known application in war, forensic science, and molecular biology, and how it led to the discovery of green fluorescent protein. Uses of bioluminescence include studying brain physiology, treatment of disease, and potential applications linking minds and machines.

    Posted by David Lemberg at 12:00 PM Return to Science and Society Podcasts Main Index

    January 18, 2006

    Dr. Graham Cooks, Distinguished Professor of Chemistry, Purdue University, 1/11/06


    Download Podcast

    Dr. Graham Cooks is a Distinguished Professor of Chemistry at Purdue University where he has spent the bulk of his career. His interests involve construction of mass spectrometers as well as their use in fundamental studies and applications. The latter interest led to construction of miniature ion trap mass spectrometers and their application to problems of trace chemical agent detection.

    Dr. Cooks's work on ionization methods has led to the desorption electrospray ionization procedure for ambient mass spectrometry. Applications of this method in security and in pharmaceutical and clinical applications are in development. Dr. Cooks’s group is also interested in molecular chirality (“handedness”) and the possible role of the amino acid serine in the biochemical origins of life.

    Dr. Cooks is a past President of the American Society for Mass Spectrometry and is on the boards of a number of scientific journals. He has been instrumental in several start-up companies in Indiana and has been honored by awards from the American Chemical Society and other organizations. His work is highly cited (one of the 100 most-cited chemists) and he has trained 95 Ph.D. students in analytical chemistry.

    Posted by David Lemberg at 10:35 AM Return to Science and Society Podcasts Main Index

    January 10, 2006

    Dr. Steven Salzberg, Director, Center for Bioinformatics and Computational Biology, and Horvitz Professor of Computer Science, University of Maryland, 1/4/06


    Download Podcast

    Dr. Steven Salzberg is the Director of the Center for Bioinformatics and Computational Biology (CBCB) and the Horvitz Professor of Computer Science at the University of Maryland, College Park. For much of the past ten years, Dr. Salzberg has been working on the analysis of genomes in collaboration with colleagues at The Institute for Genomic Research and at other research centers around the world. He was part of the team that published the human genome in 2001, and has participated in the sequencing of genomes from a long list of human pathogens, including the microbes responsible for anthrax, Lyme disease, tuberculosis, and malaria.

    Dr. Salzberg's group devotes much of its effort to the development of software for genome analysis, and they have been among the leading advocates of open-source software development in the genomics field. In 2004, Dr. Salzberg was one of the founders of the Influenza Genome Sequencing Project, which is now in the process of sequencing thousands of isolates of the influenza virus, in an effort to help design better vaccines and to better understand the nature of influenza pandemics.

    Dr. Salzberg has authored or co-authored two books and over 125 publications in leading scientific journals, and he currently serves on the editorial boards of seven journals. He is a Fellow of the American Association for the Advancement of Science and a member of the Board of Scientific Counsellors of the National Center for Biotechnology Information at NIH.

    Posted by David Lemberg at 11:51 AM Return to Science and Society Podcasts Main Index

    January 04, 2006

    Dr. Zach Hall, President, California Institute for Regenerative Medicine, 1/4/06


    Download Podcast

    Dr. Zach Hall is President of the California Institute for Regenerative Medicine. CIRM is a state agency established by Proposition 71 to promote stem cell research in California. Prop 71 passed by 59 percent of the California voters in November 2004. Over the next 10 years, the institute will disburse almost $3 billion in state bond funds to investigators at California universities and research institutions for stem cell research. The research funded by the CIRM will focus on patient and disease-specific stem cell research and other vital research opportunities for the development of life-saving regenerative medical treatments and therapies. All proposals are peer-reviewed to support the most promising scientific research.

    Previously, Dr. Hall was Director of the Zilkha Neurogenetic Institute and Senior Associate Dean for Academic Development at the Keck School of Medicine of the University of Southern California. Dr. Hall is the author and editor of An Introduction to Molecular Neurobiology, a widely used textbook, and has published more than 100 original papers and reviews in scientific journals.

    Posted by David Lemberg at 11:15 AM Return to Science and Society Podcasts Main Index

    November 07, 2005

    Dr. Alan P. Zelicoff, author, MICROBE: Are We Ready for the Next Plague?, 11/2/05


    Download Podcast

    Dr. Alan Zelicoff's new book, MICROBE: Are We Ready For the Next Plague?, co-authored by risk management expert Michael Bellomo, provides detailed accounts of the various animal-to-human transmitted viruses, bacteria, and plagues, and provides practical solutions to stop outbreaks and minimize the impact of a health epidemic. The book covers current problems in the nation’s public health infrastructure, bioterrorism, and solutions to address emerging diseases in a timely way so as to permit effective intervention.

    Dr. Zelicoff is a physician, physicist, and Senior Scientific Consultant for Ares Corporation, a risk-analysis engineering firm with offices across the U.S. He is the inventor of the Syndrome Reporting Information System, a platform-independent, networked disease monitoring tool for public health officials, physicians, veterinarians, laboratory and EMS professionals, emergency management coordinators, and decision-makers.

    Posted by David Lemberg at 12:46 PM Return to Science and Society Podcasts Main Index

    August 25, 2005

    Dr. Abdulqader Al Khayat, Executive Director, Dubai Biotechnology and Research Park (DuBiotech), 8/24/05


    Download Podcast

    The Dubai Biotechnology and Research Park (DuBiotech) is a free zone dedicated to the biotechnology industry. DuBiotech aims to be a Center of Excellence in Biotechnology, bridging research, education, and industry through national and international collaboration. The park will service the entire industry, ranging from small incubators to regional offices of key biotechnology and pharmaceutical companies to manufacturing plants. Upon completion, park development will cover over 30 million square feet of built-up area. Its infrastructure will comprise custom-made R&D facilities, including labs, clean rooms, incubators, office space, and residential facilities. The first DuBiotech facilities will be ready by mid-2006.

    Companies operating from DuBiotech will enjoy a one-stop-shop service experience, facilitating ease of entry into the region and incorporation within this diverse and rapidly developing market, in addition to specific benefits that relate to the biotech industry. The park will comprise two main initiatives—an industry cluster and the Foundation for Research and Innovation. As part of developing a cluster, DuBiotech seeks to attract a synergistic mix of biotechnology and pharmaceutical companies active in discovery, R&D, testing, production, storage, sales, and distribution. It will also attract companies offering business support services for this industry such as legal and venture capital firms specializing in the biotech industry; educational and training institutions focused on biotech; and equipment, materials, and consumables suppliers.

    The Foundation for Research and Innovation will be a specialized organization focusing on government-funded research and development in select fields including medical genetics, plant biotechnology encompassing food and agriculture, environmental biotechnology, drug discovery, pharmaceutical research, stem cell research, infectious diseases, and forensic research. Incubator facilities within the Foundation will help innovative new projects develop into productive and profitable ventures. Business development and administrative assistance offered by the Foundation will allow start-ups to concentrate on their core competencies. DuBiotech will have a regulatory framework, modeled on international best-practices.

    Dr. Abdulqader Al Khayat was appointed Executive Director of the Dubai Biotechnology and Research Park (DuBiotech) in September, 2004. Prior to this, he was Director General of Dubai Police’s General Department of Forensic Administration.

    In his role as Executive Director, Dr. Al Khayat heads the development of the Park as a center of biotechnology excellence for the region. Under his leadership, DuBiotech is creating a comprehensive infrastructure and environment to catalyze regional biotechnology development.

    Posted by David Lemberg at 06:47 PM Return to Science and Society Podcasts Main Index

    July 19, 2005

    Dr. Karen Guillemin, Assistant Professor of Biology and member of the Institute of Molecular Biology, University of Oregon, June 29, 2005

    Download Podcast

    Dr. Guillemin recently received the highest honor given to researchers early in their careers by the world's oldest life sciences organization, the American Society of Microbiology. In June, she was presented with the 2005 Merck Irving S. Sigal Award. Dr. Guillemin pursues two lines of quite different but complementary inquiry on harmful and beneficial bacteria. Dr. Guillemin's research on H. pylori, the bacteria responsible for the majority of stomach ulcers and gastric cancer, has defined how stomach cells perceive and respond to this bacterium. She uses approaches that survey the whole genome of the host and bacterium. In addition to her focus on H. pylori, Dr. Guillemin's newest line of research explores the dialogue between animals and their resident community of microbes, using the model organism zebrafish.

    Posted by David Lemberg at 08:29 PM Return to Science and Society Podcasts Main Index